rs9513877

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_052867.4(NALCN):​c.1134+9945C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.307 in 151,566 control chromosomes in the GnomAD database, including 7,560 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.31 ( 7560 hom., cov: 31)

Consequence

NALCN
NM_052867.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.41

Publications

5 publications found
Variant links:
Genes affected
NALCN (HGNC:19082): (sodium leak channel, non-selective) This gene encodes a voltage-independent, nonselective cation channel which belongs to a family of voltage-gated sodium and calcium channels that regulates the resting membrane potential and excitability of neurons. This family is expressed throughout the nervous system and conducts a persistent sodium leak current that contributes to tonic neuronal excitability. The encoded protein forms a channelosome complex that includes G-protein-coupled receptors, UNC-79, UNC-80, NCA localization factor-1, and src family tyrosine kinases. Naturally occurring mutations in this gene are associated with infantile neuroaxonal dystrophy, infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) syndrome, and congenital contractures of the limbs and face with hypotonia and developmental delay (CLIFAHDD) syndrome. A knockout of the orthologous gene in mice results in paralysis with a severely disrupted respiratory rhythm, and lethality within 24 hours after birth. [provided by RefSeq, Apr 2017]
NALCN Gene-Disease associations (from GenCC):
  • congenital contractures of the limbs and face, hypotonia, and developmental delay
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • hypotonia, infantile, with psychomotor retardation and characteristic facies 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • digitotalar dysmorphism
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Freeman-Sheldon syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Sheldon-hall syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypotonia, infantile, with psychomotor retardation and characteristic facies
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • temporal lobe epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.358 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_052867.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NALCN
NM_052867.4
MANE Select
c.1134+9945C>T
intron
N/ANP_443099.1Q8IZF0-1
NALCN
NM_001350748.2
c.1134+9945C>T
intron
N/ANP_001337677.1A0A6Q8PFS9
NALCN
NM_001350749.2
c.1134+9945C>T
intron
N/ANP_001337678.1Q8IZF0-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NALCN
ENST00000251127.11
TSL:1 MANE Select
c.1134+9945C>T
intron
N/AENSP00000251127.6Q8IZF0-1
NALCN
ENST00000470333.1
TSL:1
n.1230+9945C>T
intron
N/A
NALCN
ENST00000675332.1
c.1134+9945C>T
intron
N/AENSP00000501955.1A0A6Q8PFS9

Frequencies

GnomAD3 genomes
AF:
0.308
AC:
46589
AN:
151460
Hom.:
7560
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.233
Gnomad AMI
AF:
0.390
Gnomad AMR
AF:
0.268
Gnomad ASJ
AF:
0.257
Gnomad EAS
AF:
0.196
Gnomad SAS
AF:
0.320
Gnomad FIN
AF:
0.368
Gnomad MID
AF:
0.226
Gnomad NFE
AF:
0.362
Gnomad OTH
AF:
0.294
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.307
AC:
46594
AN:
151566
Hom.:
7560
Cov.:
31
AF XY:
0.308
AC XY:
22797
AN XY:
74046
show subpopulations
African (AFR)
AF:
0.233
AC:
9605
AN:
41250
American (AMR)
AF:
0.268
AC:
4071
AN:
15216
Ashkenazi Jewish (ASJ)
AF:
0.257
AC:
894
AN:
3472
East Asian (EAS)
AF:
0.196
AC:
1011
AN:
5164
South Asian (SAS)
AF:
0.320
AC:
1539
AN:
4812
European-Finnish (FIN)
AF:
0.368
AC:
3844
AN:
10438
Middle Eastern (MID)
AF:
0.228
AC:
66
AN:
290
European-Non Finnish (NFE)
AF:
0.362
AC:
24597
AN:
67906
Other (OTH)
AF:
0.290
AC:
611
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
1639
3278
4916
6555
8194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
486
972
1458
1944
2430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.338
Hom.:
14952
Bravo
AF:
0.295
Asia WGS
AF:
0.221
AC:
773
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.034
DANN
Benign
0.44
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9513877; hg19: chr13-101926339; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.